On March 8, WM Motor Technology announced the completion of its C round of financing, securing a total of RMB3 billion. The lead investor was Baidu Inc and the follow investors included Taihang Industrial Fund and Linear Venture. The capital secured durin
China’s leading therapeutic antibody R&D company, SinoMab Bioscience Limited (“SinoMab”) just completed a Pre-IPO round of financing, securing some hundreds of millions in RMB. This round of investment was co-led by Zhongjin Zhide Equity Investment Management (an investment arm of China International Capital Corporation Limited) and Apricot Capital. SinoMab also announced that it will begin work on its IPO. CEC Capital served as the sole financial adviser to SinoMab during this round of financing.
Taicang, Suzhou, January 2, 2019/PRNewswire / - Connect Biopharmaceuticals, a clinical-stage company that discovers and develops novel immune modulators for the treatment of autoimmune diseases and inflammation, today announces the completion of a $55 mil